NEW YORK (GenomeWeb News) - Alpha Innotech and CombiMatrix Molecular Diagnostics will integrate certain of their technologies to create a tool for comparative genomic hybridization, the companies said yesterday.
Â
The deal is centered on Alpha's AlphaScan laser scanner and CMDX's CGH arrays for neonatal screening and biomarker discovery, and calls for CMDX to integrate the AlphaScan scanner into its CGH platform.
Â
CMDX CEO Matt Watson said his firm's customers "are looking for a single integrated platform that will enable them to quickly set up a CGH laboratory and begin running experiments." He said the AlphaScan "represents a key component of that platform."
Â
Financial terms were not disclosed.